Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Hadas Nicole R.
SVP, Chief Legal Officer at Akebia Therapeutics. Filing since 25 Mar 2014.
CIK 0001602396
Company
Date
Role
Action
Shares
Amount
Of holding
AKBA
Akebia Therapeutics, Inc.
13 May 2024
SVP, Chief Legal Officer
Sold on a plan
12,016
$15.14K
1.8%
AKBA
Akebia Therapeutics, Inc.
29 Feb 2024
SVP, Chief Legal Officer
Sold at will
5,974
$9.44K
0.9%
AKBA
Akebia Therapeutics, Inc.
27 Feb 2024
SVP, Chief Legal Officer
Sold on a plan
7,411
$11.26K
1.1%
AKBA
Akebia Therapeutics, Inc.
25 May 2023
SVP, Chief Legal Officer
Sold at will
63,186
$77.27K
10.8%
AKBA
Akebia Therapeutics, Inc.
1 Mar 2023
SVP, Chief Legal Officer
Sold, plan not stated
13,034
$11.44K
4.3%
AKBA
Akebia Therapeutics, Inc.
27 Feb 2023
SVP, Chief Legal Officer
Sold, plan not stated
6,677
$5.43K
2.2%
AKBA
Akebia Therapeutics, Inc.
1 Mar 2022
SVP, Chief Legal Officer
Sold, plan not stated
14,507
$31.49K
4.6%
AKBA
Akebia Therapeutics, Inc.
28 Feb 2022
SVP, Chief Legal Officer
Sold, plan not stated
6,555
$14.12K
2.4%
AKBA
Akebia Therapeutics, Inc.
1 Apr 2021
SVP, Chief Legal Officer
Sold, plan not stated
1,060
$3.60K
0.4%
AKBA
Akebia Therapeutics, Inc.
1 Mar 2021
SVP, Chief Legal Officer
Sold, plan not stated
14,285
$48.51K
5.1%
AKBA
Akebia Therapeutics, Inc.
28 Feb 2020
SVP, Chief Legal Officer
Sold, plan not stated
7,050
$61.34K
3.2%
AKBA
Akebia Therapeutics, Inc.
2 Oct 2017
SVP, General Counsel, Sec.
Sold, plan not stated
7,803
$155.19K
7.1%
AKBA
Akebia Therapeutics, Inc.
3 Jul 2017
SVP, General Counsel, Sec.
Sold, plan not stated
1,554
$22.16K
1.4%
AKBA
Akebia Therapeutics, Inc.
3 Apr 2017
SVP, General Counsel, Sec.
Sold, plan not stated
1,556
$14.28K
1.4%
AKBA
Akebia Therapeutics, Inc.
1 Jan 2017
SVP, General Counsel, Sec.
Sold, plan not stated
1,810
$18.99K
2.1%
AKBA
Akebia Therapeutics, Inc.
1 Oct 2016
SVP, General Counsel, Sec.
Sold, plan not stated
1,556
$13.93K
1.8%
AKBA
Akebia Therapeutics, Inc.
5 Jul 2016
SVP, General Counsel, Sec.
Sold, plan not stated
1,557
$11.63K
1.8%
AKBA
Akebia Therapeutics, Inc.
4 Apr 2016
SVP, General Counsel, Sec.
Sold, plan not stated
1,556
$14.64K
1.8%
AKBA
Akebia Therapeutics, Inc.
4 Jan 2016
SVP, General Counsel, Sec.
Sold, plan not stated
1,811
$22.24K
2.7%
AKBA
Akebia Therapeutics, Inc.
2 Oct 2015
SVP, General Counsel, Sec.
Sold, plan not stated
1,484
$12.86K
2.2%
AKBA
Akebia Therapeutics, Inc.
2 Jul 2015
SVP, General Counsel, Sec.
Sold, plan not stated
1,484
$14.16K
2.2%
AKBA
Akebia Therapeutics, Inc.
2 Apr 2015
SVP, General Counsel, Sec.
Sold, plan not stated
1,483
$13.48K
1.9%
AKBA
Akebia Therapeutics, Inc.
2 Jan 2015
VP General Counsel & Secretary
Sold, plan not stated
1,715
$19.66K
2.3%
AKBA
Akebia Therapeutics, Inc.
25 Mar 2014
See Remarks
Bought
3,500
$59.50K
4.8%
24 decisions on file.
